Literature DB >> 12907878

Mechanical injury and repair of cells.

Katsuya Miyake1, Paul L McNeil.   

Abstract

OBJECTIVE: To concisely review the field of cell plasma membrane disruption (torn cell surface) and repair. MAIN POINTS: Plasma membrane disruption is a common form of cell injury under physiologic conditions, after trauma, in certain muscular dystrophies, and during certain forms of clinical intervention. Rapid repair of a disruption is essential to cell survival and involves a complex and active cell response that includes membrane fusion and cytoskeletal activation. Tissues, such as cardiac and skeletal muscle, adapt to a disruption injury by hypertrophying. Cells adapt by increasing the efficiency of their resealing response.
CONCLUSION: Plasma membrane disruption is an important cellular event in both health and disease. The disruption repair mechanism is now well understood at the cellular level, but much remains to be learned at the molecular level. Cell and tissue level adaptational responses to the disruption either prevent its further occurrence or facilitate future repairs. Therapeutically useful drugs might result if, using this accumulating knowledge, chemical agents can be developed that can enhance repair or adaptive responses.

Entities:  

Keywords:  NASA Discipline Cell Biology; Non-NASA Center

Mesh:

Substances:

Year:  2003        PMID: 12907878     DOI: 10.1097/01.CCM.0000081432.72812.16

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  18 in total

1.  Contractile function and sarcolemmal permeability after acute low-load resistance exercise with blood flow restriction.

Authors:  Mathias Wernbom; Gøran Paulsen; Tormod S Nilsen; Jonny Hisdal; Truls Raastad
Journal:  Eur J Appl Physiol       Date:  2011-09-27       Impact factor: 3.078

Review 2.  Plasma Membrane Repair: A Central Process for Maintaining Cellular Homeostasis.

Authors:  Alisa D Blazek; Brian J Paleo; Noah Weisleder
Journal:  Physiology (Bethesda)       Date:  2015-11

Review 3.  Rehabilitation and the single cell.

Authors:  William M Bement; Hoi-Ying E Yu; Brian M Burkel; Emily M Vaughan; Andrew G Clark
Journal:  Curr Opin Cell Biol       Date:  2006-12-14       Impact factor: 8.382

4.  Structural and functional recovery of electropermeabilized skeletal muscle in-vivo after treatment with surfactant poloxamer 188.

Authors:  John M Collins; Florin Despa; Raphael C Lee
Journal:  Biochim Biophys Acta       Date:  2007-01-25

Review 5.  A role for myokines in muscle-bone interactions.

Authors:  Mark W Hamrick
Journal:  Exerc Sport Sci Rev       Date:  2011-01       Impact factor: 6.230

6.  Impaired recovery of dysferlin-null skeletal muscle after contraction-induced injury in vivo.

Authors:  Joseph A Roche; Richard M Lovering; Robert J Bloch
Journal:  Neuroreport       Date:  2008-10-29       Impact factor: 1.837

7.  Extensive mononuclear infiltration and myogenesis characterize recovery of dysferlin-null skeletal muscle from contraction-induced injuries.

Authors:  Joseph A Roche; Richard M Lovering; Renuka Roche; Lisa W Ru; Patrick W Reed; Robert J Bloch
Journal:  Am J Physiol Cell Physiol       Date:  2009-11-18       Impact factor: 4.249

8.  Dysferlin deficiency and the development of cardiomyopathy in a mouse model of limb-girdle muscular dystrophy 2B.

Authors:  Thomas H Chase; Gregory A Cox; Lisa Burzenski; Oded Foreman; Leonard D Shultz
Journal:  Am J Pathol       Date:  2009-10-29       Impact factor: 4.307

Review 9.  The Pivotal Role of Mitsugumin 53 in Cardiovascular Diseases.

Authors:  Wenhua Jiang; Manling Liu; Chunhu Gu; Heng Ma
Journal:  Cardiovasc Toxicol       Date:  2020-10-01       Impact factor: 3.231

10.  TRIM72 is required for effective repair of alveolar epithelial cell wounding.

Authors:  Seong Chul Kim; Thomas Kellett; Shaohua Wang; Miyuki Nishi; Nagaraja Nagre; Beiyun Zhou; Per Flodby; Konstantin Shilo; Samir N Ghadiali; Hiroshi Takeshima; Rolf D Hubmayr; Xiaoli Zhao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-08-08       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.